Free Trial

SOPHiA GENETICS (SOPH) News Today

SOPHiA GENETICS logo
$3.71 -0.04 (-1.09%)
As of 07/18/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SOPH Latest News

Sophia Genetics, Precision for Medicine enter strategic partnership
Morgan Stanley Keeps Their Hold Rating on SOPHiA GENETICS (SOPH)
SOPHiA GENETICS (SOPH) Gets a Buy from BTIG
SOPHiA GENETICS (SOPH) Receives a Buy from BTIG
Sophia Genetics price target lowered to $5 from $6 at BTIG
SOPHiA GENETICS (SOPH) Gets a Buy from RBC Capital
Sophia Genetics sees FY25 revenue $72M-$76M, consensus $74.51M
Craig-Hallum Sticks to Its Buy Rating for SOPHiA GENETICS (SOPH)
Sophia Genetics announces adoption of MSK-Access
RBC Capital Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)
Morgan Stanley Reaffirms Their Hold Rating on SOPHiA GENETICS (SOPH)
Get SOPHiA GENETICS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter.

SOPH Media Mentions By Week

SOPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SOPH
News Sentiment

0.00

0.57

Average
Medical
News Sentiment

SOPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SOPH Articles
This Week

0

2

SOPH Articles
Average Week

Get SOPHiA GENETICS News Delivered to You Automatically

Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SOPH) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners